Program in Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
O1 Advance in CFD, biotissue and food science As of June 16 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
O2 Hemorheology in health and diseases - 1 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
O3 Hemorheology in health and diseases - 2 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
O4 Red cell deformability in human and mamalians |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Plenary Lectures Plenary lectures are proposed by three societies (ESCHM, ISCH and ISB) and conducted by invited speakers who are authority in the field of clinical hemorheology, biorheology and microcirculation. These lectures are held without any parallel sessions and include a broad range of content i.e., basic concept and recent progress on the related science and technology. All attendees can enjoy plenary lectures. Discussion including Q/A depends on the chairperson’s decision. These lectures are distributed in live streaming or in video presentation. Rising Star Award Sessions Rising Star Awards are presented to outstanding mid-career investigators who are making major and independent contributions to an advance in the field of clinical hemorheology, biorheology and microcirculation. This is a first trial in this joint meeting to activate this online meeting and to encourage mid-career scientists. Awardees are to attend the joint meeting and to present their major work in this session. Final qualification is going to be announced on the joint meeting website. These sessions are multiple and distributed in live streaming manner. Keynote Lectures Keynote lectures are given by leaders on the specific topics relating to clinical hemorheology, biorheology and microcirculation. Keynote speakers usually introduce the background and future perspective of their expertise and raise the interest of audience in the related fields. Keynote lectures are held sometimes prior to the relating symposium and distributed in live streaming manner to enable live discussion. Symposia Symposia are the main part of this joint meeting and cover a wide range of topics in clinical hemorheology, biorheology and microcirculation. Organizers usually propose to hold a symposium by organizing several symposiasts, and scientific committee accepts these symposia based on scientific criteria including impacts and novelty. Final discussion depends on organizers. Symposia are distributed in live streaming but sometimes in video due to global time zone. Free Communications This session is composed of free presentations submitted freely and categorized according to the topics of this meeting. These includes both live presentation and video demonstration of prerecorded power point slide show series associated with speakers’ narration and camera. These depend on the time zone and speakers’ schedule. In the latter case, audience can post question and speakers can post answer in the chat box, and hence Q/A is possible. ePosters This session displays video series of electronically prepared one slide digital poster associated with speakers’ narration and camera. Audience can post question and speakers can post answer in the chat box, and hence poster networking is possible. This session is distributed in an on-demand fashion during the joint meeting period and further until the end of November 2021. Note: All sessions of this joint meeting are distributed as on-demand archives until the end of November 2021. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
page top | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||